Products Liability
| Poison Prevention Packaging Act |
|
| The Poison Prevention Packaging Act (Act) was passed to prevent unintentional child poisonings. The Act requires special packaging to protect children from injury or illness as a result of handling, using, or ingesting certain drugs and household substances. The Act requires child-resistant packaging for such products. A child-resistant package is one that is significantly difficult for children under the age of five to open. More... |
|
|
| The Reimportation of Prescription Drugs |
|
| Health care costs, especially the cost of prescription drugs, have increased dramatically in recent years. Americans pay higher costs for prescription drugs than consumers abroad. U.S. consumers, particularly the elderly, have demanded changes that would make prescription drugs more affordable. This article discusses past and current federal legislation dealing with the reimportation of prescription drugs. Safety has been one of the major issues in the battle over the reimportation of prescription drugs. Current law prohibits the reimportation of prescription drugs until the Secretary of Health and Human Services (HHS) certifies the safety of reimported prescription drugs. More... |
|
|
| The Bioterrorism Act of 2002 |
|
| After the terrorist acts that caused the collapse of the World Trade Center in New York on September 11, 2001, the U.S. Congress passed The Bioterrorism Act of 2002. The full name of the law is the Public Health Security and Bioterrorism Preparedness Response Act of 2002. The main goal of the law is to protect the food supply from bioterrorism. The law also covers drinking water security and controls on dangerous biological agents and toxins. The main provisions of The Bioterrorism Act of 2002 are discussed below. More... |
|
|
| Use of Investigational Drugs in Human Clinical Studies |
|
| In a clinical study, human volunteers receive investigational drug therapy. The effects of the treatment are compared with a control group of human volunteers who receive either the standard treatment or a placebo (a sugar pill that has no therapeutic benefit). Researchers are able to conclude whether the experimental drug had a better outcome than the standard treatment. The experimental drug might produce a better outcome, but it might not work. It could prove dangerous or even deadly.
More... |
|
|
| Learned Intermediary Doctrine and Oral Contraceptives |
|
| In 1985, the Massachusetts Supreme Court carved out an exception to the learned intermediary doctrine for oral contraceptives. The court held that the manufacturer of an oral contraceptive could not rely on warnings to doctors to satisfy its duty to warn More... |
|
|